NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NASDAQ·Healthcare·Biotechnology
$22.91
+4.80%
Mkt Cap $2.97B
EPS — Estimate vs Actual
Mkt Cap
$2.97B
P/E
—
Fwd P/E
—
P/S
131.59
Rev TTM
—
EPS TTM
-$1.81
NASDAQ·Healthcare·Biotechnology
$22.91
+4.80%
Mkt Cap $2.97B
Mkt Cap
$2.97B
P/E
—
Fwd P/E
—
P/S
131.59
Rev TTM
—
EPS TTM
-$1.81